Medical Condition News

RSS

Gut microbes may help explain why obesity and type 2 diabetes become harder to reverse

This review describes how gut microbial messengers, including SCFAs, microbiota-modified bile acids, neuroactive metabolites, and extracellular vesicles, may shape obesity and type 2 diabetes through the microbiota-gut-brain axis.

17 Jun 2026

Neurological disorders may raise traumatic brain injury risk in older adults

For traumatic brain injury (TBI) and certain brain diseases, it looks like the risk may go in both directions, according to a study published on June 17, 2026, in Neurology®, the medical journal of the American Academy of Neurology.

17 Jun 2026

Microplastics worsen liver damage under high-fat dietary conditions

Microplastics – minuscule pieces of plastic broken down from larger plastic waste – are a growing concern for human health, especially for the liver.

17 Jun 2026

AGA experts highlight benefits and limits of colorectal cancer screening tests

As new colorectal cancer screening guidance draws attention to the growing number of testing options, the American Gastroenterological Association urges patients and primary care providers to understand how those options compare.

17 Jun 2026

Preoperative radiation boosts immunotherapy response in brain metastases

A new study led by researchers at The University of Texas MD Anderson Cancer Center demonstrated that pre-operative radiation therapy for brain metastases not only targets tumor cells directly but also can activate immune pathways that can make tumors more receptive to immunotherapy.

17 Jun 2026

Digital heart twins could improve atrial fibrillation treatment planning

A cross-University paper led by researchers at Queen Mary University of London, published in the Journal of Physiology shows how better 'digital twins' could help doctors treating people with Atrial Fibrillation.

17 Jun 2026

Onion-loving gene linked to lower diabetes and blood pressure risk

Imagine if a doctor could look at your DNA and predict not just your disease risk, but also which foods you're drawn to – and whether those cravings are quietly protecting you.

17 Jun 2026

AI accurately measures mesothelioma tumors for better treatment decisions

Physicians and researchers at the Netherlands Cancer Institute have developed an AI model that outperforms physicians at evaluating treatment response in pleural mesothelioma.

17 Jun 2026

Trauma-focused therapy safely improves PTSD symptoms in psychosis patients

New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London and published in The Lancet Psychiatry has found that people with psychosis experiencing Post Traumatic Stress Disorder (PTSD) can benefit from a Trauma-Focused therapy integrated with Cognitive Behavior Therapy for psychosis (CBTp).

17 Jun 2026

Study links commercial cannabis markets to increased addiction

Removing criminal penalties for possessing cannabis for personal use, or introducing tightly controlled legalisation of cannabis, does not appear to increase levels of cannabis use.

17 Jun 2026

Researchers uncover genetic cause of spontaneous spinal CSF leaks

Researchers at Cedars-Sinai Health Sciences University and Johns Hopkins University have identified genetic mutations that may explain why some people develop a spontaneous cerebrospinal fluid (CSF) leak in the spine.

17 Jun 2026

First human trial targets aging immune cells for healthier immunity

A first-in-human clinical trial of an immune rejuvenation therapy designed to restore the function of worn-out T cells is expected to begin later this year, building on research led by UCL scientists into the mechanisms of immune aging.

17 Jun 2026

AI-designed drug for Parkinson's begins first human trial

Insilico Medicine ("Insilico", HKEX: 3696), a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced it has achieved the first clinical milestone in its co-development collaboration with Hygtia Therapeutics with the completion of first-in-human dosing in the Phase I study of ISM8969.

17 Jun 2026

Novel gene therapy appears to be safe for Friedreich ataxia cardiomyopathy

A new gene therapy appears to be safe in patients diagnosed with Friedreich ataxia cardiomyopathy, a progressive and fatal inherited cardiac disease, according to a phase 1 clinical trial led by Weill Cornell Medicine researchers.

17 Jun 2026

Ingestible vibrating pill identifies anorexia nervosa patients at risk of relapse

A vibrating pill could help doctors determine if a patient with anorexia nervosa may have a higher risk of relapse, according to a new study by UCLA Health.

17 Jun 2026

Adverse life experiences alter brain structure linked to schizophrenia

Carnegie Mellon University and University of California, San Francisco researchers found that childhood trauma, poverty, social isolation and other adverse life experiences are associated with brain changes linked to schizophrenia-spectrum disorders - findings that could help researchers identify people at risk earlier and develop interventions before severe symptoms emerge.

17 Jun 2026

USC study reveals nuanced Alzheimer's genetic risk in Hispanic populations

Researchers at the USC Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC analyzed brain imaging and clinical data from more than 17,000 participants across five major aging and Alzheimer's disease studies.

17 Jun 2026

Smartphone apps and wearables help heart disease patients stay active

Smartphone apps, fitness trackers and wearable devices help people with heart disease get more physical activity in their daily lives, according to an analysis of previous research published today in the Journal of the American Heart Association, an open-access, peer-reviewed journal of the American Heart Association.

17 Jun 2026

Experts outline a multidisciplinary approach to managing clinical obesity

The rapid rise of GLP-1 medications such as semaglutide and tirzepatide has transformed obesity treatment.

17 Jun 2026

Researchers at Tulane University School of Medicine strengthen breast cancer research workflows with advanced liquid handling

A laboratory at the Tulane University School of Medicine has enhanced its drug screening and tumor modelling workflows by adopting advanced liquid handling solutions from INTEGRA Biosciences, including the PIPETBOY GENIUS serological pipet controller and VIAFLO electronic pipettes.

From Tulane University School of Medicine 17 Jun 2026